News In Brief
This article was originally published in The Gray Sheet
Tavenner confirmed as CMS chief. DePuy phases out metal hips. More news
You may also be interested in...
CMS principal deputy administrator Andy Slavitt steps in as acting administrator as Marilyn Tavenner plans to depart the agency after five years running the agency. She will leave at the end of February.
Changes announced at European trade groups Eucomed, MedTech Europe as Guy Lebeau steps down from leadership posts; former FDA Commissioner Mark McClellan joins J&J board. More personnel news.
Although Myriad says the Supreme Court’s recent ruling that isolated genes can’t be patented does not leave its BRCA1 and BRCA2 assays unprotected, other diagnostic companies are now incorporating the genes into their tests for the likelihood of inheriting cancer at a fraction of the previous cost.